1	1	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Introduction	_	_	NN	_	_	_	_	_


1	Protein	_	_	NN	_	_	_	_	_


1	N-glycosylation	_	_	NNP	_	_	_	_	_
2	is	_	_	VBZ	_	_	_	_	_
3	a	_	_	DT	_	_	_	_	_
4	critical	_	_	JJ	_	_	_	_	_
5	post-translational	_	_	JJ	_	_	_	_	_
6	modification	_	_	NN	_	_	_	_	_
7	,	_	_	,	_	_	_	_	_
8	in	_	_	IN	_	_	_	_	_
9	which	_	_	WDT	_	_	_	_	_
10	an	_	_	DT	_	_	_	_	_
11	oligosaccharide	_	_	NN	_	_	_	_	_
12	moiety	_	_	NN	_	_	_	_	_
13	is	_	_	VBZ	_	_	_	_	_
14	transferred	_	_	VBN	_	_	_	_	_
15	from	_	_	IN	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	glycosyl	_	_	NN	_	_	_	_	_
18	carrier	_	_	NN	_	_	_	_	_
19	dolichol-phosphate	_	_	NN	_	_	_	_	_
20	(	_	_	-LRB-	_	_	_	_	_
21	Dol-P	_	_	NNP	_	_	_	_	_
22	)	_	_	-RRB-	_	_	_	_	_
23	and	_	_	CC	_	_	_	_	_
24	covalently	_	_	RB	_	_	_	_	_
25	attaches	_	_	VBZ	_	_	_	_	_
26	to	_	_	TO	_	_	_	_	_
27	a	_	_	DT	_	_	_	_	_
28	polypeptide	_	_	NN	_	_	_	_	_
29	chain	_	_	NN	_	_	_	_	_
30	via	_	_	IN	_	_	_	_	_
31	an	_	_	DT	_	_	_	_	_
32	asparagine	_	_	NN	_	_	_	_	_
33	residue	_	_	NN	_	_	_	_	_
34	.	_	_	.	_	_	_	_	_


1	Following	_	_	VBG	_	_	_	_	_
2	protein	_	_	NN	_	_	_	_	_
3	conjugation	_	_	NN	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	oligosaccharide	_	_	NN	_	_	_	_	_
7	is	_	_	VBZ	_	_	_	_	_
8	further	_	_	RBR	_	_	_	_	_
9	modified	_	_	VBN	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	increasing	_	_	VBG	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	functional	_	_	JJ	_	_	_	_	_
14	and	_	_	CC	_	_	_	_	_
15	structural	_	_	JJ	_	_	_	_	_
16	diversity	_	_	NN	_	_	_	_	_
17	of	_	_	IN	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	proteome	_	_	NN	_	_	_	_	_
20	.	_	_	.	_	_	_	_	_


1	Indeed	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	this	_	_	DT	_	_	_	_	_
4	modification	_	_	NN	_	_	_	_	_
5	is	_	_	VBZ	_	_	_	_	_
6	crucial	_	_	JJ	_	_	_	_	_
7	for	_	_	IN	_	_	_	_	_
8	proper	_	_	JJ	_	_	_	_	_
9	protein	_	_	NN	_	_	_	_	_
10	folding	_	_	NN	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	oligomerization	_	_	NN	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	quality	_	_	NN	_	_	_	_	_
15	control	_	_	NN	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	sorting	_	_	NN	_	_	_	_	_
18	,	_	_	,	_	_	_	_	_
19	and	_	_	CC	_	_	_	_	_
20	transport	_	_	NN	_	_	_	_	_
21	.	_	_	.	_	_	_	_	_


1	Accordingly	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	even	_	_	RB	_	_	_	_	_
4	slight	_	_	JJ	_	_	_	_	_
5	variations	_	_	NNS	_	_	_	_	_
6	in	_	_	IN	_	_	_	_	_
7	protein	_	_	NN	_	_	_	_	_
8	glycosylation	_	_	NN	_	_	_	_	_
9	can	_	_	MD	_	_	_	_	_
10	markedly	_	_	RB	_	_	_	_	_
11	affect	_	_	VB	_	_	_	_	_
12	proteins	_	_	NNS	_	_	_	_	_
13	structure	_	_	NN	_	_	_	_	_
14	and	_	_	CC	_	_	_	_	_
15	function	_	_	NN	_	_	_	_	_
16	and	_	_	CC	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	thus	_	_	RB	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	glycosylation	_	_	NN	_	_	_	_	_
21	disorders	_	_	NNS	_	_	_	_	_
22	result	_	_	VBP	_	_	_	_	_
23	in	_	_	IN	_	_	_	_	_
24	a	_	_	DT	_	_	_	_	_
25	wide	_	_	JJ	_	_	_	_	_
26	range	_	_	NN	_	_	_	_	_
27	of	_	_	IN	_	_	_	_	_
28	clinical	_	_	JJ	_	_	_	_	_
29	syndromes	_	_	NNS	_	_	_	_	_
30	affecting	_	_	VBG	_	_	_	_	_
31	practically	_	_	RB	_	_	_	_	_
32	every	_	_	DT	_	_	_	_	_
33	organ	_	_	NN	_	_	_	_	_
34	system	_	_	NN	_	_	_	_	_
35	.	_	_	.	_	_	_	_	_


1	Dehydrodolichyl	_	_	NNP	_	_	_	_	_
2	diphosphate	_	_	NN	_	_	_	_	_
3	synthase	_	_	NN	_	_	_	_	_
4	(	_	_	-LRB-	_	_	_	_	_
5	DHDDS	_	_	NNP	_	_	_	_	_
6	)	_	_	-RRB-	_	_	_	_	_
7	together	_	_	RB	_	_	_	_	_
8	with	_	_	IN	_	_	_	_	_
9	Nogo-B	_	_	NNP	_	_	_	_	_
10	receptor	_	_	NN	_	_	_	_	_
11	(	_	_	-LRB-	_	_	_	_	_
12	NgBR	_	_	NNP	_	_	_	_	_
13	)	_	_	-RRB-	_	_	_	_	_
14	form	_	_	VBP	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	human	_	_	JJ	_	_	_	_	_
17	cis	_	_	NN	_	_	_	_	_
18	-prenyltransferase	_	_	NN	_	_	_	_	_
19	complex	_	_	NN	_	_	_	_	_
20	.	_	_	.	_	_	_	_	_


1	This	_	_	DT	_	_	_	_	_
2	complex	_	_	NN	_	_	_	_	_
3	catalyzes	_	_	VBZ	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	formation	_	_	NN	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	dehydrodolichyl	_	_	NN	_	_	_	_	_
8	diphosphate	_	_	NN	_	_	_	_	_
9	(	_	_	-LRB-	_	_	_	_	_
10	DHDD	_	_	NNP	_	_	_	_	_
11	)	_	_	-RRB-	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	a	_	_	DT	_	_	_	_	_
14	long-chain	_	_	JJ	_	_	_	_	_
15	polyprenyl	_	_	NN	_	_	_	_	_
16	serving	_	_	VBG	_	_	_	_	_
17	as	_	_	IN	_	_	_	_	_
18	a	_	_	DT	_	_	_	_	_
19	precursor	_	_	NN	_	_	_	_	_
20	for	_	_	IN	_	_	_	_	_
21	Dol-P	_	_	NNP	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	DHDD	_	_	NNP	_	_	_	_	_
2	is	_	_	VBZ	_	_	_	_	_
3	synthesized	_	_	VBN	_	_	_	_	_
4	by	_	_	IN	_	_	_	_	_
5	chain	_	_	NN	_	_	_	_	_
6	elongation	_	_	NN	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	farnesyl	_	_	NN	_	_	_	_	_
9	diphosphate	_	_	NN	_	_	_	_	_
10	(	_	_	-LRB-	_	_	_	_	_
11	FPP	_	_	NN	_	_	_	_	_
12	)	_	_	-RRB-	_	_	_	_	_
13	via	_	_	IN	_	_	_	_	_
14	multiple	_	_	JJ	_	_	_	_	_
15	condensations	_	_	NNS	_	_	_	_	_
16	with	_	_	IN	_	_	_	_	_
17	isopentenyl	_	_	NN	_	_	_	_	_
18	diphosphate	_	_	NN	_	_	_	_	_
19	(	_	_	-LRB-	_	_	_	_	_
20	IPP	_	_	NNP	_	_	_	_	_
21	)	_	_	-RRB-	_	_	_	_	_
22	(	_	_	-LRB-	_	_	_	_	_


1	Figure	_	_	NN	_	_	_	_	_
2	1	_	_	CD	_	_	_	_	_


1	A	_	_	NN	_	_	_	_	_
2	)	_	_	-RRB-	_	_	_	_	_
3	.	_	_	.	_	_	_	_	_


1	Importantly	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	while	_	_	IN	_	_	_	_	_
4	previous	_	_	JJ	_	_	_	_	_
5	studies	_	_	NNS	_	_	_	_	_
6	revealed	_	_	VBD	_	_	_	_	_
7	that	_	_	IN	_	_	_	_	_
8	DHDDS	_	_	NNP	_	_	_	_	_
9	is	_	_	VBZ	_	_	_	_	_
10	required	_	_	VBN	_	_	_	_	_
11	and	_	_	CC	_	_	_	_	_
12	sufficient	_	_	JJ	_	_	_	_	_
13	for	_	_	IN	_	_	_	_	_
14	this	_	_	DT	_	_	_	_	_
15	catalytic	_	_	JJ	_	_	_	_	_
16	activity	_	_	NN	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	NgBR	_	_	NNP	_	_	_	_	_
19	induces	_	_	VBZ	_	_	_	_	_
20	an	_	_	DT	_	_	_	_	_
21	increase	_	_	NN	_	_	_	_	_
22	in	_	_	IN	_	_	_	_	_
23	the	_	_	DT	_	_	_	_	_
24	expression	_	_	NN	_	_	_	_	_
25	and	_	_	CC	_	_	_	_	_
26	activity	_	_	NN	_	_	_	_	_
27	of	_	_	IN	_	_	_	_	_
28	the	_	_	DT	_	_	_	_	_
29	complex	_	_	NN	_	_	_	_	_
30	but	_	_	CC	_	_	_	_	_
31	exhibits	_	_	VBZ	_	_	_	_	_
32	no	_	_	DT	_	_	_	_	_
33	catalytic	_	_	JJ	_	_	_	_	_
34	activity	_	_	NN	_	_	_	_	_
35	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	line	_	_	NN	_	_	_	_	_
3	with	_	_	IN	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	important	_	_	JJ	_	_	_	_	_
6	role	_	_	NN	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	DHDDS	_	_	NN	_	_	_	_	_
9	in	_	_	IN	_	_	_	_	_
10	protein	_	_	NN	_	_	_	_	_
11	glycosylation	_	_	NN	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	mutations	_	_	NNS	_	_	_	_	_
14	in	_	_	IN	_	_	_	_	_
15	DHDDS	_	_	NN	_	_	_	_	_
16	were	_	_	VBD	_	_	_	_	_
17	recently	_	_	RB	_	_	_	_	_
18	shown	_	_	VBN	_	_	_	_	_
19	to	_	_	TO	_	_	_	_	_
20	cause	_	_	VB	_	_	_	_	_
21	autosomal	_	_	JJ	_	_	_	_	_
22	recessive	_	_	JJ	_	_	_	_	_
23	retinitis	_	_	NN	_	_	_	_	_
24	pigmentosa	_	_	NN	_	_	_	_	_
25	,	_	_	,	_	_	_	_	_
26	a	_	_	DT	_	_	_	_	_
27	fatal	_	_	JJ	_	_	_	_	_
28	glycosylation	_	_	NN	_	_	_	_	_
29	disorder	_	_	NN	_	_	_	_	_
30	,	_	_	,	_	_	_	_	_
31	and	_	_	CC	_	_	_	_	_
32	developmental	_	_	JJ	_	_	_	_	_
33	epileptic	_	_	JJ	_	_	_	_	_
34	encephalopathies	_	_	NNS	_	_	_	_	_
35	.	_	_	.	_	_	_	_	_


1	Despite	_	_	IN	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	clinical	_	_	JJ	_	_	_	_	_
4	importance	_	_	NN	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	DHDDS	_	_	NNP	_	_	_	_	_
7	,	_	_	,	_	_	_	_	_
8	it	_	_	PRP	_	_	_	_	_
9	was	_	_	VBD	_	_	_	_	_
10	not	_	_	RB	_	_	_	_	_
11	structurally	_	_	RB	_	_	_	_	_
12	and	_	_	CC	_	_	_	_	_
13	functionally	_	_	RB	_	_	_	_	_
14	characterized	_	_	VBN	_	_	_	_	_
15	to	_	_	TO	_	_	_	_	_
16	date	_	_	NN	_	_	_	_	_
17	.	_	_	.	_	_	_	_	_


1	Conserved	_	_	JJ	_	_	_	_	_
2	domains	_	_	NNS	_	_	_	_	_
3	search	_	_	NN	_	_	_	_	_
4	analysis	_	_	NN	_	_	_	_	_
5	reveals	_	_	VBZ	_	_	_	_	_
6	that	_	_	IN	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	cis	_	_	FW	_	_	_	_	_
9	-prenyltransferase	_	_	FW	_	_	_	_	_
10	catalytic	_	_	JJ	_	_	_	_	_
11	domain	_	_	NN	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	DHDDS	_	_	NNP	_	_	_	_	_
14	(	_	_	-LRB-	_	_	_	_	_
15	residues	_	_	NNS	_	_	_	_	_
16	24	_	_	CD	_	_	_	_	_
17	–	_	_	TO	_	_	_	_	_
18	248	_	_	CD	_	_	_	_	_
19	)	_	_	-RRB-	_	_	_	_	_
20	is	_	_	VBZ	_	_	_	_	_
21	homologous	_	_	JJ	_	_	_	_	_
22	to	_	_	TO	_	_	_	_	_
23	undecaprenyl	_	_	NN	_	_	_	_	_
24	pyrophosphate	_	_	NN	_	_	_	_	_
25	synthase	_	_	NN	_	_	_	_	_
26	(	_	_	-LRB-	_	_	_	_	_
27	UPPS	_	_	NN	_	_	_	_	_
28	)	_	_	-RRB-	_	_	_	_	_
29	,	_	_	,	_	_	_	_	_
30	a	_	_	DT	_	_	_	_	_
31	well	_	_	RB	_	_	_	_	_
32	characterized	_	_	VBN	_	_	_	_	_
33	bacterial	_	_	JJ	_	_	_	_	_
34	cis	_	_	NN	_	_	_	_	_
35	-prenyltransferase	_	_	NN	_	_	_	_	_
36	.	_	_	.	_	_	_	_	_


1	Consisting	_	_	VBG	_	_	_	_	_
2	of	_	_	IN	_	_	_	_	_
3	seven	_	_	CD	_	_	_	_	_
4	α-helices	_	_	NNS	_	_	_	_	_
5	and	_	_	CC	_	_	_	_	_
6	six	_	_	CD	_	_	_	_	_
7	β-strands	_	_	NNS	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	this	_	_	DT	_	_	_	_	_
10	domain	_	_	NN	_	_	_	_	_
11	forms	_	_	VBZ	_	_	_	_	_
12	dimers	_	_	NNS	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	with	_	_	IN	_	_	_	_	_
15	a	_	_	DT	_	_	_	_	_
16	hydrophobic	_	_	JJ	_	_	_	_	_
17	catalytic	_	_	JJ	_	_	_	_	_
18	tunnel	_	_	NN	_	_	_	_	_
19	surrounded	_	_	VBN	_	_	_	_	_
20	by	_	_	IN	_	_	_	_	_
21	two	_	_	CD	_	_	_	_	_
22	α-helices	_	_	NNS	_	_	_	_	_
23	and	_	_	CC	_	_	_	_	_
24	four	_	_	CD	_	_	_	_	_
25	β−strands	_	_	NNS	_	_	_	_	_
26	within	_	_	IN	_	_	_	_	_
27	each	_	_	DT	_	_	_	_	_
28	monomer	_	_	NN	_	_	_	_	_
29	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	contrast	_	_	NN	_	_	_	_	_
3	with	_	_	IN	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	N-terminal	_	_	NNP	_	_	_	_	_
6	cis	_	_	FW	_	_	_	_	_
7	-prenyltransferase	_	_	NN	_	_	_	_	_
8	homology	_	_	NN	_	_	_	_	_
9	domain	_	_	NN	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	C-terminus	_	_	NNP	_	_	_	_	_
13	of	_	_	IN	_	_	_	_	_
14	human	_	_	JJ	_	_	_	_	_
15	DHDDS	_	_	NNP	_	_	_	_	_
16	does	_	_	VBZ	_	_	_	_	_
17	not	_	_	RB	_	_	_	_	_
18	converge	_	_	VB	_	_	_	_	_
19	with	_	_	IN	_	_	_	_	_
20	any	_	_	DT	_	_	_	_	_
21	known	_	_	VBN	_	_	_	_	_
22	conserved	_	_	VBN	_	_	_	_	_
23	domains	_	_	NNS	_	_	_	_	_
24	.	_	_	.	_	_	_	_	_


1	Intriguingly	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	despite	_	_	IN	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	low	_	_	JJ	_	_	_	_	_
6	level	_	_	NN	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	conservation	_	_	NN	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	a	_	_	DT	_	_	_	_	_
11	C-terminal	_	_	JJ	_	_	_	_	_
12	domain	_	_	NN	_	_	_	_	_
13	is	_	_	VBZ	_	_	_	_	_
14	common	_	_	JJ	_	_	_	_	_
15	to	_	_	TO	_	_	_	_	_
16	long-chain	_	_	JJ	_	_	_	_	_
17	cis	_	_	NN	_	_	_	_	_
18	-prenyltransferases	_	_	NNS	_	_	_	_	_
19	and	_	_	CC	_	_	_	_	_
20	is	_	_	VBZ	_	_	_	_	_
21	absent	_	_	JJ	_	_	_	_	_
22	in	_	_	IN	_	_	_	_	_
23	short-	_	_	JJ	_	_	_	_	_
24	and	_	_	CC	_	_	_	_	_
25	medium-chain	_	_	JJ	_	_	_	_	_
26	cis	_	_	NN	_	_	_	_	_
27	-prenyltransferases	_	_	NNS	_	_	_	_	_
28	(	_	_	-LRB-	_	_	_	_	_


1	Figure	_	_	NN	_	_	_	_	_
2	1	_	_	CD	_	_	_	_	_


1	B	_	_	NN	_	_	_	_	_
2	)	_	_	-RRB-	_	_	_	_	_
3	.	_	_	.	_	_	_	_	_


1	Nevertheless	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	its	_	_	PRP$	_	_	_	_	_
4	structure	_	_	NN	_	_	_	_	_
5	and	_	_	CC	_	_	_	_	_
6	functional	_	_	JJ	_	_	_	_	_
7	role	_	_	NN	_	_	_	_	_
8	remains	_	_	VBZ	_	_	_	_	_
9	elusive	_	_	JJ	_	_	_	_	_
10	.	_	_	.	_	_	_	_	_


1	Recently	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	we	_	_	PRP	_	_	_	_	_
4	have	_	_	VBP	_	_	_	_	_
5	devised	_	_	VBN	_	_	_	_	_
6	an	_	_	DT	_	_	_	_	_
7	efficient	_	_	JJ	_	_	_	_	_
8	procedure	_	_	NN	_	_	_	_	_
9	for	_	_	IN	_	_	_	_	_
10	overexpression	_	_	NN	_	_	_	_	_
11	and	_	_	CC	_	_	_	_	_
12	purification	_	_	NN	_	_	_	_	_
13	of	_	_	IN	_	_	_	_	_
14	human	_	_	JJ	_	_	_	_	_
15	DHDDS	_	_	NN	_	_	_	_	_
16	in	_	_	IN	_	_	_	_	_
17	Escherichia	_	_	NNP	_	_	_	_	_
18	coli	_	_	NNP	_	_	_	_	_
19	.	_	_	.	_	_	_	_	_


1	Similar	_	_	JJ	_	_	_	_	_
2	to	_	_	TO	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	bacterial	_	_	JJ	_	_	_	_	_
5	homolog	_	_	NN	_	_	_	_	_
6	UPPS	_	_	NN	_	_	_	_	_
7	,	_	_	,	_	_	_	_	_
8	we	_	_	PRP	_	_	_	_	_
9	showed	_	_	VBD	_	_	_	_	_
10	that	_	_	IN	_	_	_	_	_
11	human	_	_	JJ	_	_	_	_	_
12	DHDDS	_	_	NN	_	_	_	_	_
13	forms	_	_	VBZ	_	_	_	_	_
14	active	_	_	JJ	_	_	_	_	_
15	homodimers	_	_	NNS	_	_	_	_	_
16	.	_	_	.	_	_	_	_	_


1	However	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	molecular	_	_	JJ	_	_	_	_	_
5	details	_	_	NNS	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	interaction	_	_	NN	_	_	_	_	_
9	interface	_	_	NN	_	_	_	_	_
10	and	_	_	CC	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	overall	_	_	JJ	_	_	_	_	_
13	architecture	_	_	NN	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	enzyme	_	_	NN	_	_	_	_	_
17	remained	_	_	VBD	_	_	_	_	_
18	obscure	_	_	JJ	_	_	_	_	_
19	.	_	_	.	_	_	_	_	_


1	Here	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	we	_	_	PRP	_	_	_	_	_
4	determine	_	_	VBP	_	_	_	_	_
5	a	_	_	DT	_	_	_	_	_
6	structural	_	_	JJ	_	_	_	_	_
7	model	_	_	NN	_	_	_	_	_
8	for	_	_	IN	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	full-length	_	_	JJ	_	_	_	_	_
11	human	_	_	JJ	_	_	_	_	_
12	DHDDS	_	_	NN	_	_	_	_	_
13	homodimer	_	_	NN	_	_	_	_	_
14	using	_	_	VBG	_	_	_	_	_
15	an	_	_	DT	_	_	_	_	_
16	integrative	_	_	JJ	_	_	_	_	_
17	approach	_	_	NN	_	_	_	_	_
18	that	_	_	WDT	_	_	_	_	_
19	combines	_	_	VBZ	_	_	_	_	_
20	multiple	_	_	JJ	_	_	_	_	_
21	sources	_	_	NNS	_	_	_	_	_
22	of	_	_	IN	_	_	_	_	_
23	information	_	_	NN	_	_	_	_	_
24	,	_	_	,	_	_	_	_	_
25	including	_	_	VBG	_	_	_	_	_
26	a	_	_	DT	_	_	_	_	_
27	radioligand-based	_	_	JJ	_	_	_	_	_
28	enzyme	_	_	NN	_	_	_	_	_
29	kinetics	_	_	NN	_	_	_	_	_
30	assay	_	_	NN	_	_	_	_	_
31	,	_	_	,	_	_	_	_	_
32	size-exclusion	_	_	NN	_	_	_	_	_
33	chromatography	_	_	NN	_	_	_	_	_
34	multi-angle	_	_	NN	_	_	_	_	_
35	light	_	_	NN	_	_	_	_	_
36	scattering	_	_	NN	_	_	_	_	_
37	(	_	_	-LRB-	_	_	_	_	_
38	SEC-MALS	_	_	NNP	_	_	_	_	_
39	)	_	_	-RRB-	_	_	_	_	_
40	,	_	_	,	_	_	_	_	_
41	small-angle	_	_	JJ	_	_	_	_	_
42	X-ray	_	_	NN	_	_	_	_	_
43	scattering	_	_	NN	_	_	_	_	_
44	(	_	_	-LRB-	_	_	_	_	_
45	SAXS	_	_	NN	_	_	_	_	_
46	)	_	_	-RRB-	_	_	_	_	_
47	,	_	_	,	_	_	_	_	_
48	and	_	_	CC	_	_	_	_	_
49	hydrogen	_	_	NN	_	_	_	_	_
50	–	_	_	:	_	_	_	_	_
51	deuterium	_	_	NN	_	_	_	_	_
52	exchange	_	_	NN	_	_	_	_	_
53	mass-spectrometry	_	_	NN	_	_	_	_	_
54	(	_	_	-LRB-	_	_	_	_	_
55	HDX-MS	_	_	NNP	_	_	_	_	_
56	)	_	_	-RRB-	_	_	_	_	_
57	.	_	_	.	_	_	_	_	_

